Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

Go back to Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
(NASDAQ: IMUX) Delayed: 14.97 +0.22 (1.49%)
Previous Close $14.75    52 Week High
Open $14.48    52 Week Low
Day High $15.41    P/E N/A 
Day Low $14.12    EPS
Volume 67,971